Control of Myopia Using Novel Spectacle Lens Designs

Running, not enrolling · Not applicable

Conditions studied: Juvenile Myopia

In brief

Randomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical trial of 36-month duration to evaluate the safety and efficacy of a novel spectacle lens design in reducing the progression of juvenile myopia.

Key facts

Study ID
NCT03623074
Run by
SightGlass Vision, Inc.
People needed
266
Starts
2018-07-16
Expected to finish
2026-12-31
Last updated by the study team
2026-05-05

Who can join

Age: 6 and older, up to 10. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.